Selectis Health, Inc.
GBCS
$5.74
$0.030.53%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -54.73% | -30.50% | -6.98% | 8.22% | 10.80% |
| Total Revenue | -54.73% | -30.50% | -6.98% | 8.22% | 8.93% |
| Cost of Revenue | -49.34% | -24.91% | -10.99% | 12.49% | 9.98% |
| Gross Profit | -73.97% | -49.27% | 5.50% | -4.99% | 5.38% |
| SG&A Expenses | 3.96% | -12.78% | 18.38% | -30.47% | -5.95% |
| Depreciation & Amortization | -36.72% | -8.21% | 5.87% | -2.51% | -11.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.31% | -21.61% | -4.07% | -0.46% | 5.25% |
| Operating Income | -366.64% | -199.38% | -306.68% | 74.65% | 41.05% |
| Income Before Tax | 2,890.52% | 1,157.33% | -39.34% | 146.82% | -138.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2,737.47% | 1,094.88% | -39.48% | 146.82% | -138.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,737.47% | 1,094.88% | -39.48% | 146.82% | -138.78% |
| EBIT | -366.64% | -199.38% | -306.68% | 74.65% | 41.05% |
| EBITDA | -2,039.31% | -1,483.13% | -104.41% | 108.49% | 75.31% |
| EPS Basic | 2,671.53% | 1,071.44% | -40.74% | 146.14% | -140.12% |
| Normalized Basic EPS | -145.17% | -198.73% | -6.06% | 105.74% | 51.84% |
| EPS Diluted | 2,383.77% | 963.64% | -32.30% | 145.59% | -140.12% |
| Normalized Diluted EPS | -117.63% | -166.19% | -6.06% | 105.74% | 51.84% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 12.64% | 12.25% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |